Anpac bio-medical science co. ltd.

Other-Pharmaceuticals

ANPC


Executive/
Director

Price

  • Last Close
  • $ 0.34
    $ +0.02 5.85 %
    Jun 27, 2024
  • 52-Week High/Low
  • $2.46 - $0.29
  • YTD
  • 0%

  • Trading Volume
  • 104
  • Market Cap Full
  • $ 13M
  • Shares Outstanding
  • 38.2M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% 13% -64.7% -5.4% -38.2% -
Q2 - - - - 4% -29.7% -33.2% -3.9% -2% -
Q3 - - - - 8% -23% 962.5% -73.3% - -
Q4 - - - - 41.7% -62.4% 52% -19.1% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 -55.1% -17.5% 66.7% -12.7% - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-77%281%-81%-61%0%

Earnings

2016 2017 2021 2022
Q1 - - -7.4 -2.6
Q2 - - - -
Q3 - - - -
Q4 - - - -
A 0 0 -1.4 -0.4

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022
Mar - - - -
Jun - - 12.5 23.6
Sep - - - -
Dec 8.9 11.2 13.6 38.2

Financial Ratios

202020192018
Asset Management
Inventory / Stock Turnover 24.4 19.3 -
Fixed Asset Turnover 0.7 0.4 -
Total Asset Turnover 0.4 0.2 -
Leverage
Debt Ratio - - -
Debt – Equity Ratio - - -
Interest Coverage 6.7 -7.4 -
Equity multiplier 8.7 -1.9 -